Supernus Pharmaceuticals (0LB2.L) Stock Price
$46.09 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
9 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Supernus Pharmaceuticals, AI stock picks, stock alerts and much more.
0LB2.L AI Stock Analysis
AI stock analysis for 0LB2.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Supernus Pharmaceuticals (0LB2.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Supernus Pharmaceuticals (0LB2.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Supernus Pharmaceuticals (0LB2.L), currently trading at $46.09, will... Sign up to access price prediction.
About 0LB2.L
-
Supernus Pharmaceuticals, Inc.
-
Symbol
0LB2.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
2.6B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
News
0LB2.L Alternative Data
Web Traffic
Supernus Pharmaceuticals receives an estimated 16956 monthly visitors to supernus.com, which is up by 13.4% over the last month.
-
Web Traffic
16956
-
Change from Previous Month
13.4%
-
3 Month Change
46.2%
-
YoY Change
46.2%
Reddit Mentions
Supernus Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Supernus Pharmaceuticals has 330 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
330
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
2.2%
-
YoY Change
2.2%
LinkedIn Followers
21,819 are following Supernus Pharmaceuticals on LinkedIn, up by 1.9% over the last month.
-
LinkedIn Followers
21819
-
Daily Change
1.9%
-
1 Month Change
1.9%
-
3 Month Change
8.3%
-
YoY Change
8.3%
Business Outlook
According to employee reviews, the business outlook among employees at Supernus Pharmaceuticals is 47 out of 100 (neutral).
-
Business Outlook
47
-
Change from Previous Month
0%
-
3 Month Change
14.6%
-
YoY Change
14.6%
LinkedIn Employees
According to LinkedIn, Supernus Pharmaceuticals has 743 employees, up by 4.1% over the last month.
-
LinkedIn Employees
743
-
Daily Change
4.1%
-
1 Month Change
4.1%
-
3 Month Change
4.2%
-
YoY Change
4.2%
News Mentions
Supernus Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0LB2.L Financials
0LB2.L Key Metrics
-
Total Revenue
$174.2M
-
Net Income
$15.3M
-
Earnings per Share
$0.28
-
Free cash flow
$44.2M
-
EBITDA
$45.2M
-
EBITDA Ratio
0.259688
-
Total Assets
$1.4B
0LB2.L 2-year Revenue & Income
0LB2.L 2-year Free Cash Flow
0LB2.L Technicals
0LB2.L SMA
0LB2.L RSI
FAQ
What's the current price of Supernus Pharmaceuticals (0LB2.L) Stock?
The price of an Supernus Pharmaceuticals (0LB2.L) share is $46.09.
What's the market cap of Supernus Pharmaceuticals?
The current market cap of Supernus Pharmaceuticals is 2.6B.
What are some stocks similar to Supernus Pharmaceuticals (0LB2.L) that investors often compare it to?
Supernus Pharmaceuticals (0LB2.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Supernus Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Supernus Pharmaceuticals' stock price to be around $49.38 in 2026. Starting from the current price of $46.09, this represents a 7.1% change in price, indicating a bullish outlook for the stock.
How to buy Supernus Pharmaceuticals (0LB2.L) Stock?
Supernus Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Supernus Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.